- Denbury soars after rumors of a takeover by Exxon Mobil.
- American Airlines raised its quarterly sales on Tuesday, expected to rise by about 13%. The company was up 2.7% in premarket trading.
- Eli Lilly - U.S. Food and Drug Administration inspectors recently found several new quality control problems at an Eli Lilly plant, which is already under federal investigation for manufacturing defects, a government document seen by Reuters shows.
- Zscaler was down 3.6% in pre-market trading after announcing the resignation of its chairman, Amit Sinha.
- Samsung Electronics and Taiwan Semiconductor fall after Washington's decision to restrict exports to China.
- Chinese electric vehicle battery maker Contemporary Amperex (CATL) expects third-quarter profit to nearly triple.
- Meta Platforms hosts a conference on augmented reality.
- Solvay signs a memorandum of understanding to source rare earth carbonate.
- Givaudan confirms its annual guidance despite somewhat weak organic growth.
- Bio-Rad and Qiagen are considering a tie-up, according to the Wall Street Journal.
- Royal Boskalis will delist from Euronext Amsterdam in early November.
- AstraZeneca's COVID-19 nasal vaccine fails to elicit strong immune response in Phase I study.
- PureTech Health ends merger discussions with Nektar Therapeutics.
- Skanska wins $150 million contract to upgrade US subway stations.
- Leonteq falls after suspicions of aiding money laundering revealed by the Financial Times.